108 related articles for article (PubMed ID: 28925165)
1. [Effects of sanguisorba tannins and saponins compatibility on pharmacokinetic parameters of catechin, epicatechin and ziyuglycoside Ⅰ in rats].
Xiong YA; Yang M
Zhongguo Zhong Yao Za Zhi; 2016 Oct; 41(19):3661-3667. PubMed ID: 28925165
[TBL] [Abstract][Full Text] [Related]
2. A rapid and sensitive UHPLC-MS/MS method for the determination of ziyuglycoside I and its application in a preliminary pharmacokinetic study in healthy and leukopenic rats.
Zhu LJ; Chen L; Bai CF; Wu AG; Liang SC; Huang FH; Cao SS; Yang L; Zou WJ; Wu JM
Biomed Pharmacother; 2020 Mar; 123():109756. PubMed ID: 31864212
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic Effects of Ziyuglycoside II, a Major Active Compound of Sanguisorba officinalis L.
Nam SH; Lkhagvasuren K; Seo HW; Kim JK
Phytother Res; 2017 Sep; 31(9):1449-1456. PubMed ID: 28718964
[TBL] [Abstract][Full Text] [Related]
4. Phytotherapeutic Activities of Sanguisorba officinalis and its Chemical Constituents: A Review.
Jang E; Inn KS; Jang YP; Lee KT; Lee JH
Am J Chin Med; 2018; 46(2):299-318. PubMed ID: 29433389
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of Sanguisorba officinalis root extract on HYBID (KIAA1199)-mediated hyaluronan degradation and skin wrinkling.
Yoshida H; Yamazaki K; Komiya A; Aoki M; Kasamatsu S; Murata T; Sayo T; Cilek MZ; Okada Y; Takahashi Y
Int J Cosmet Sci; 2019 Feb; 41(1):12-20. PubMed ID: 30485450
[TBL] [Abstract][Full Text] [Related]
6. [THE CATECHINS OF SANGUISORBA L].
DZHEMUKHADZE KM; AZOVTSEV GR
Dokl Akad Nauk SSSR; 1965 Mar; 161():715-7. PubMed ID: 14292103
[No Abstract] [Full Text] [Related]
7. Anti-Diabetic and Hepato-Renal Protective Effects of Ziyuglycoside II Methyl Ester in Type 2 Diabetic Mice.
Son DJ; Hwang SY; Kim MH; Park UK; Kim BS
Nutrients; 2015 Jul; 7(7):5469-83. PubMed ID: 26198246
[TBL] [Abstract][Full Text] [Related]
8. The Tannins from
Tu J; Li Q; Zhou B
Molecules; 2021 Jul; 26(13):. PubMed ID: 34279393
[No Abstract] [Full Text] [Related]
9. Development and validation of a quantification method for ziyuglycoside I and II in rat plasma: Application to their pharmacokinetic studies.
Ye W; Fu H; Xie L; Zhou L; Rao T; Wang Q; Shao Y; Xiao J; Kang D; Wang G; Liang Y
J Sep Sci; 2015 Jul; 38(13):2340-7. PubMed ID: 25885584
[TBL] [Abstract][Full Text] [Related]
10. A Sample and Sensitive HPLC-MS/MS Method for Simultaneous Determination of Ziyuglycoside I and Its Metabolite Ziyuglycoside II in Rat Pharmacokinetics.
Li ZF; Zhou MY; Tan T; Zhong CC; Wang Q; Pan LL; Luo YY; Yang SL; Feng YL; Ouyang H
Molecules; 2018 Feb; 23(3):. PubMed ID: 29495641
[TBL] [Abstract][Full Text] [Related]
11. Anti-wrinkle activity of ziyuglycoside I isolated from a Sanguisorba officinalis root extract and its application as a cosmeceutical ingredient.
Kim YH; Chung CB; Kim JG; Ko KI; Park SH; Kim JH; Eom SY; Kim YS; Hwang YI; Kim KH
Biosci Biotechnol Biochem; 2008 Feb; 72(2):303-11. PubMed ID: 18256460
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous determination of catechin, epicatechin and epicatechin gallate in rat plasma by LC-ESI-MS/MS for pharmacokinetic studies after oral administration of Cynomorium songaricum extract.
Zhang QH; Wang WB; Li J; Chang YX; Wang YF; Zhang J; Zhang BL; Gao XM
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jan; 880(1):168-71. PubMed ID: 22153330
[TBL] [Abstract][Full Text] [Related]
13. Ziyuglycoside II induces cell cycle arrest and apoptosis through activation of ROS/JNK pathway in human breast cancer cells.
Zhu X; Wang K; Zhang K; Zhu L; Zhou F
Toxicol Lett; 2014 May; 227(1):65-73. PubMed ID: 24680927
[TBL] [Abstract][Full Text] [Related]
14. Effects of rhubarb tannins on renal function in rats with renal failure.
Yokozawa T; Fujioka K; Oura H; Nonaka G; Nishioka I
Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):13-8. PubMed ID: 8336394
[TBL] [Abstract][Full Text] [Related]
15. Saponins from
Chen X; Li B; Gao Y; Ji J; Wu Z; Chen S
Front Pharmacol; 2017; 8():130. PubMed ID: 28360858
[TBL] [Abstract][Full Text] [Related]
16. [Effect of total saponins from Sanguisorba officinalis on megakaryocyte progenitor cells proliferation, differentiation and relative receptor expression].
Dai YP; Gao XP; Wu JM; Li X; Huang FH; Zou WJ
Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1685-9. PubMed ID: 25095385
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of Ziyuglycoside I and Ziyuglycoside II in Rat Plasma by UPLC-MS/MS.
Shen X; Wang Z; Li W; Mei S; Ma S; Wang X; Wen C; Chen F; Zheng G
Int J Anal Chem; 2024; 2024():7971021. PubMed ID: 38463657
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive characterization of the in vitro and in vivo metabolites of ziyuglycoside I in rat microsome, intestinal flora, excretion specimen and fresh tissues based on LC-Q-TOF/MS.
Wang G; Fu H; Ye W; Zheng X; Xiao J; Kang D; Rao T; Shao Y; Xie L; Liang Y
J Pharm Biomed Anal; 2016 Sep; 128():191-200. PubMed ID: 27268222
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and blood-brain barrier penetration of (+)-catechin and (-)-epicatechin in rats by microdialysis sampling coupled to high-performance liquid chromatography with chemiluminescence detection.
Wu L; Zhang QL; Zhang XY; Lv C; Li J; Yuan Y; Yin FX
J Agric Food Chem; 2012 Sep; 60(37):9377-83. PubMed ID: 22953747
[TBL] [Abstract][Full Text] [Related]
20. Development of a novel sectional multiple filtering scheme for rapid screening and classifying metabolites of ziyuglycoside II in rat liver and excreta specimen based on high-resolution mass spectrometry.
Xiao J; Chen H; Fu H; Ye W; Rao T; Shao Y; Kang D; Shen B; Xie L; Wang G; Liang Y
J Pharm Biomed Anal; 2016 Sep; 129():310-319. PubMed ID: 27454082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
